Skip to main content

Poster Presentation - The Notch ligand DLL1 exerts pro-carcinogenic effects in human breast cancer luminal A MCF-7 cells



Abstract 

Background: Breast cancer (BC) is the most common cancer in women and has a high rate of relapse and death. The Notch signaling pathway plays an important role in normal breast development and homeostasis. Dysregulation of Notch receptors and its ligands Jagged1, Jagged2, and DLL4 has been detected in BC and implicated in tumor development, progression, drug resistance, and recurrence. The Notch ligand DLL1 has emerged as a player in BC as its expression is undetectable in normal breast tissues, but moderate to high in BC. In this study, we examined the role of DLL1 in BC luminal A MCF-7 cells. Methodology: DLL1 siRNA and recombinant DLL1 protein were used to evaluate the effects of DLL1 in MCF-7 cells. Gene expression was analyzed by qRT-PCR and immunoblotting. Cell growth and proliferation were assessed by trypan blue exclusion and MTT methods. Microscopy and scratch wound-healing assays were used to evaluate colony formation and cell migration. Findings: In MCF-7 cells, DLL1 downregulation reduced proliferation, colony formation efficiency, and migration. On the other hand, treatment with recombinant DLL1, which activates the Notch signaling pathway, increased MCF-7 cell proliferation and migration, confirming that DLL1 contributes to these processes in these luminal A BC cells. Conclusion: These findings provide evidence that DLL1 contributes to the pro-carcinogenic effects of luminal A MCF-7 cells by promoting clonogenic growth, cell proliferation, and migration.

Biography

                                                       
Dr holds a PhD in Biology from the Instituto de Biologia Experimental e Tecnológica, Portugal. From 2002 to 2008 she worked as Post-Doctoral fellow in the Instituto Gulbenkian de Ciência, Portugal, on projects that contributed to the understanding of how HO1-1 protein affords cytoprotective and anti-inflammatory effects in various diseases. After that, she developed research in cancer. First on the role of HDAC inhibitors on hematologic malignancies and then on the mechanisms by which p16 protein exerts anti-oncogenic effects in osteosarcoma and on the mechanisms underlying the stromal fibroblast transformation in breast cancer. Since 2014, she has been a scientist at Instituto de Biologia Experimental e Tecnológica, Portugal, where she works on projects in the fields of biopharmaceutical process development and oncology. Her main scientific interests relates to the mechanisms underlying cancer development and therapy.

Comments

  1. Luis PefriSeptember 13, 2021 at 2:25 AM

    Really glad to read this post. Best Camp 4 Cancer arranges provides details about Cancer research charity events at Camp 4 Cancer.
    Australian cancer charities

    ReplyDelete

Post a Comment

Popular posts from this blog

Poster Presentation - Influence of NECC (Nutrition and Exercise Center for Cancer Patients) on survival and body composition in Gastrointestinal Cancer Patients

Abstract BACKGROUND : Gastrointestinal cancer patients are particularly predisposed to develop cancer cachexia. Cachectic patients are characterized by loss of adipose tissue as well as skeletal muscle wasting which has a tremendous impact on quality of life and survival (1, 4). In terms of improvement for this multifactorial syndrome, Klinikum rechts der Isar (MRI) in Munich, Germany has founded NECC, a treatment concept including nutrition intervention and an individual training program. METHODS : In this study we focused on patients with pancreatic (n =15) and upper gastrointestinal cancer (n = 21). Body composition using CT images was analyzed initially, 4 weeks, 3 months and 6 months after initial visit of NECC (Image 1). To underline the outcome, NECC patients were matched to adequate partners who correspond in age, gender, diagnosis with TNM classification and type of surgery. The control group does not receive any further support concerning nutrition and physical exercise...
2 comments
Read more

Past Conference Report - Cancer Research

With great support from our Collaborators and Organizing Committee, PULSUS Conferences successfully completed the “Cancer 2018” which was held at Edinburgh, Scotland on March 26-27, 2018. We would like to thank our Keynote Speakers for the conference - Hiroshi Kobayashi , Chiba University, Japan, William T. Beck , University of Illinois, USA, Shalini Gupta , King George Medical College, India, Antonio Gomez-Munoz , University Of The Basque Country, Spain, Barbara DeVivo , Westmont University, USA. for their support in making this event a great success. We would like to extend our thanks to our collaborators “ Sudanese Medical Research Association ”, “ Uganda Cancer Society ” and “ Pharmaceutical Society of Uganda ” for their constant support. It wouldn’t have been possible without the support of our Media Partners who helped us in promoting this event. We thank our Media partners for their support in helping us reach a greater audience. We also would like to thank all o...
Post a Comment
Read more

Poster Presentation - The Immunogradient of CD8+ cell density in the tumour-stroma interface zone predicts overall survival of patients with hormone receptor-positive invasive ductal breast carcinoma

Abstract Statement of the Problem: Tumour-infiltrating lymphocytes (TIL) are associated with better prognosis in triple-negative and HER2-positive breast cancer (1, 2), and TIL assessment by digital image analysis (DIA) has been successfully implemented in colorectal and other cancers (3). However, results in hormone receptor-positive breast cancer (HRBC) based on manual scoring remain contradictory (2). Here we used an automated DIA method to extract the prognostic value of novel Immunogradient indicators in CD8+ cell density profiles in HRBC. Methodology & Theoretical Orientation: Surgically excised HRBC samples from 102 patients were immunohistochemically stained for CD8, digitized and analyzed by the HALO™ platform. The DIA data were subsampled by a hexagonal grid and explicit rules were then used to extract the tumor-stroma interface zone (IZ) and compute novel Immunogradient indicators from TIL density profiles across the IZ. The prognostic value was evaluated by sur...
Post a Comment
Read more